Black Deal 12 months of Premium for €49.99 instead of €74.99 12 months €49.99 instead of €74.99 until Sun, Dec 13
Get the deal

mittee - FACEIT level 6, 1,280 ELO

USA
On FACEIT since 2022 261 matches tracked 73 matches in 30 days
Last updated:

mittee at a glance

Level 6 1,280 ELO best map Inferno (68%)
Level 6

Last 20 matches compared with 2,998 players in this group: K/R, ADR and win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 54%
1.00
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.45 ConsistencyShare of matches with a rating of 0.90 or higher. 60%
K/R
0.74
better than 61% of players
Level 6 avg: 0.71
Last 12 months
ADR
83.4
better than 70% of players
Level 6 avg: 78.5
Last 12 months
Win rate
55%
better than 72% of players
Level 6 avg: 48%
Last 12 months

Facts

71 ELO Next goal ELO to level 7
5 Comebacks last 90 days
1 W · 7 L Overtime in overtime
Mirage Favorite map 65 of 261 matches
Inferno 68% Map pool tip weakest: Mirage 37%
22:00-3:00 Playing times most active
On Thursdays Best time 62% win rate vs. 49%
FormMapsTiming

71 ELO away from level 7. 5 wins after trailing at halftime (last 90 days). 8 matches in overtime, 1 of them won (last 90 days). Most played: Mirage (65 of 261 matches). Strongest map: Inferno (68% win rate, 28 matches). Weakest: Mirage (37%, 65 matches). Plays most between 22:00 and 3:00 (based on 261 matches). Best results on Thursdays: 62% win rate vs. 49% overall (26 matches).

About mittee

mittee plays CS2 on FACEIT level 6 with 1,280 ELO. The stats cover 261 matches. The strongest map is Inferno with a 68% win rate in 28 matches. Most played: Mirage with 65 matches and a 37% win rate. Biggest strength: Rounds with first kill at 12%, better than 81% of level 6 players. mittee won 5 matches after trailing at halftime (last 90 days). Last 20 matches: 11 wins, 9 losses, +23 ELO. mittee does best on Thursdays: 62% win rate in 26 matches.